SALUSIN-␣ AND -␤ are bioactive peptides identified by bioinformatics analyses of a human full-length cDNA library (24) . Salusins are reportedly generated from preprosalusin mRNA derived from the torsin family 2 member A (TOR2A) gene via alternative splicing. TOR2A transcripts appear to be ubiquitously expressed in normal human tissues; in contrast, preprosalusin transcripts display low expression levels in many tissues with the exception of bone marrow, endocrine glands (adrenal, pancreas, thyroid, testis, and pituitary glands), the brain (caudate nucleus, hippocampus, and thalamus), and blood vessels [vascular endothelial cells (ECs) and smooth muscle cells (VSMCs)] (30) . A previous investigation suggested abundant immunohistochemical localization of salusin-␣ in the epithelial tissues throughout organs in normal healthy rats, whereas localization of salusin-␤ was observed primarily in neuroendocrine and hematopoietic systems (27) . Therefore, salusin-␣ and -␤ are expected to act in specific cell types and exert distinct effects. Specific receptors for salusins as well as the physiological roles of the peptides in the majority of these organs have not been identified, although salusins are known to promote proliferation and intracellular Ca 2ϩ mobilization in VSMCs (24) .
We have focused on the pathophysiological roles of salusins in atherosclerotic diseases (17, 29) . Salusin-␤, which is enriched in human atheroma, accelerates the formation of foam cells in human monocyte-derived macrophages via upregulation of acyl-CoA:cholesterol acyltransferase-1 (29) , a key enzyme in macrophage foam cell formation. Chronic administration of salusin-␤ promoted the development of macrophagedriven atherosclerosis in apolipoprotein E (ApoE)-deficient (ApoE Ϫ/Ϫ ) mice; conversely, infusion of salusin-␣ ameliorated atherosclerosis (17) . Furthermore, infusion of antiserum against salusin-␤ suppressed the development of atherosclerosis in both untreated and salusin-␤-administrated ApoE Ϫ/Ϫ mice; meanwhile, antiserum against salusin-␣ cancelled the salusin-␣-induced inhibition of atherosclerotic lesions in ApoE Ϫ/Ϫ mice. Therefore, both salusin-␣ and -␤ participate in the regulation of atherosclerosis, exerting opposite effects on disease progression.
One of the earliest pathological features of atherosclerosis is dysfunction of vascular ECs, which triggers the infiltration of monocytes/macrophages or plasma-active constituents into the subendothelial space, resulting in increased atherosclerosis susceptibility in the large arteries (21, 28) . Nakashima et al. (18) noted that the proinflammatory adhesion molecules ICAM-1 and VCAM-1 are induced in ECs in the shoulder regions of atherosclerotic plaques in ApoE Ϫ/Ϫ mice, which facilitates monocyte adhesion to vascular walls. Previously, Cybulsky et al. (1) demonstrated that genetic deficiency of the Vcam1 D4D allele, but not of the Icam1 gene, led to a reduction of atherosclerotic lesions in LDL receptor-deficient (Ldlr Ϫ/Ϫ ) mice, suggesting that the progression of atherosclerosis is mediated mainly through the induction of VCAM-1 in ECs, particularly in the early phase of the disease. Preprosalusin and TOR2A transcripts are expressed abundantly in vascular ECs as well as in VSMCs (24); however, the physiological and pathophysiological implications of salusins in ECs have not been established. Thus, this study attempted to clarify the unknown roles of salusins in proinflammatory responses in ECs during the development of atherosclerosis.
The present data revealed that salusin-␤, but not salusin-␣, directly induces inflammatory responses in vascular ECs through NF-B signaling. This action promotes monocyte adhesion to ECs, which is suggestive of a novel role of salusin-␤ in atherogenesis.
MATERIALS AND METHODS
Reagents. Synthetic salusin-␣ and -␤ were purchased from the Peptide Institute (Osaka, Japan). Anti-salusin-␤ antiserum was developed in rabbits, as previously described (22) . (E)-3-(4-methylphenylsulfonyl)-2-propenenitrile (Bay 11-7082), N-acetyl cysteine (NAC), and 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY-294002) were acquired from Sigma-Aldrich (St. Louis, MO). 1,4-diamino-2,3-dicyano-1,4-bis(2-amino-phenylthio)butadiene (U-0126) was purchased from Calbiochem/EMD Biosciences (San Diego, CA). Diferuloylmethane (curcumin) was obtained from Cayman Chemical (Ann Arbor, MI). All Table 1 . PCR primers used in this study Primer Sequence PCR Product, bp
In vivo experiments (mice)
CD68 Forward 5=- GACCTACATCAGAGCCCGAGT-3=  96  Reverse  5=-CGCCA TGAA TGTCCACTG-3=  ICAM-1  Forward  5=-GGCACCCAGCAGAAGTTGTT-3=  154  Reverse  5=-CCTCAGTCACCTCTACCAAG-3=  VCAM-1  Forward  5=-TCTCTCAGGAAATGCCACCC-3=  215  Reverse  5=-CACAGCCAATAGCAGCACAC-3=  E-selectin  Forward  5=-TCCTCTGGAGAGTGGAGTGC-3=  67  Reverse  5=-GGTGGGTCAAAGCTTCACAT-3=  Monocyte chemoattractant protein-1  Forward  5=-CATCCACGTGTTGGCTCA-3=  76  Reverse  5=-GATCATCTTGCTGGTGAATGAGT-3=  TNF- other chemicals were commercial products of the highest available grade of purity. Animals. All procedures involving animals were performed according to the protocols approved by our faculties (15, 17) . Ldlr Ϫ/Ϫ mice were fed chow or a high-cholesterol diet (HCD; CRF-1 supplemented with 1.4% cholesterol and 0.4% cholic acid, Oriental Yeast) for 2 wk beginning at 8 wk of age. Leukocyte numbers in the peripheral blood were measured by VetScan (ABAXIS, Sunnyvale, CA). Systolic blood pressure was determined via the tail-cuff method using a MK-2000 (Muromachi Kikai, Tokyo, Japan). Plasma lipid profiles were analyzed using standard enzymatic methods.
Infusion of antiserum against salusin-␤ into mice. Nonimmune serum or anti-salusin-␤ antiserum was infused (1.4 g·kg Ϫ1 ·h Ϫ1 ) for 2 wk into HCD-fed Ldlr Ϫ/Ϫ mice aged 8 wk using osmotic minipumps (model 1007D, Alzet, Cupertino, CA) as previously described (17) . The anti-salusin-␤ antiserum used in this study was identical to that used in our previous investigation (17) .
Immunohistochemistry. Immunohistochemical analysis of the murine aorta was performed as described in our previous report (15) . Briefly, the isolated aortic tree and root were fixed with 4% paraformaldehyde in PBS; subsequently, samples were frozen, sectioned (6 m thickness), and mounted on glass slides as required. VCAM-1 was probed with an anti-VCAM-1 antibody (AbD Serotec, Oxford, UK) and its appropriate horseradish peroxidase (HRP)-labeled secondary antibody. To conduct en face immunohistochemical analysis, isolated aortic specimens were fixed with 4% paraformaldehyde in PBS followed by permeabilization with 0.4% Triton X-100 in PBS. Specimens were then blocked with 5% BSA and then subsequently incubated with primary antibodies raised against p50 NF-B (Gene Tex, Irvine, CA) or monocyte/macrophage antigen-2 (MOMA-2; AbD Serotec). Specimens were labeled with fluorescent-or HRPlabeled secondary antibodies and 4=,6-diamidino-2-phenylindole (DAPI). Fluorescence images were obtained via confocal microscopy (LSM510, Carl Zeiss, Thornwood, NY). Images were analyzed with ImageJ software (National Institutes of Health, Bethesda, MD).
Cell culture. Confluent human umbilical vein ECs (HUVECs; Cambrex, Walkersville, MD) from three to seven passages were used in the experiments as previously described (12) (13) (14) (15) . Cells were treated with salusins in the presence or absence of inhibitors (Bay 11-7082, curcumin, or NAC). Human monocytic THP-1 cells (DS Pharma Biomedical, Osaka, Japan) were cultured in RPMI-1640 medium supplemented with 10% FBS (14) .
Monocyte-HUVEC adhesion. Monocyte-HUVEC adhesion was evaluated essentially as previously described (14) . HUVECs were stimulated with salusins at 1-30 nM for 6 h followed by a rinse with PBS. Subsequently, THP-1 cells (1 ϫ 10 5 cells/well of 24-well plates) labeled with Calcein red-orange (Invitrogen, Carlsbad, CA) were added to HUVEC cultures and incubated for 10 min. After a wash, THP-1 cells bound to the HUVEC surface were measured with a fluorescence microplate reader (excitation: 568 nm and emission: 590 nm, Mithras LB940, Berthold Technologies, Bad Wildbad, Germany).
3-(4,5-Dimetylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay.
The cytotoxicity of salusins in HUVECs was evaluated with a 3-(4,5-dimetylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay kit (Cayman Chemical) according to the manufacturer's instructions. Optical absorbance at 570 nm was measured using a microplate reader (Wako, Osaka, Japan) as statistical values.
RT-PCR. Total RNA from the murine aorta or HUVECs was converted to first-strand cDNA. mRNA expression levels were quantified by real-time RT-PCR essentially as previously described (12, 15) . The primers used in the present study are shown in Table 1 .
Immunoblot analysis. Protein expression levels were determined by immunoblot analysis as previously described (12) (13) (14) (15) . Briefly, HUVECs were lysed and separated by electrophoresis on a 7.5-10% polyacrylamide gel followed by transfer to nitrocellulose membranes. Membranes were blocked and reacted overnight at 4°C with each antibody against ICAM-1 (Gene Tex), VCAM-1 (Santa Cruz Biotechnology, Santa Cruz, CA), pan IB-␣ (Anaspec, Fremont, CA), or phospho-IB-␣ (Assay Biotech, Sunnyvale, CA). Proteins were detected with the appropriate secondary antibodies and ECL reagent (Bio-Rad Laboratories, Richmond, CA).
Immunocytochemistry. HUVECs stimulated with salusins were fixed with 4% paraformaldehyde, permeabilized with 0.4% Triton X-100, and blocked with 5% BSA for 30 min. Next, cells were stained with an anti-p50 NF-kB antibody (Gene Tex) and the appropriate fluorescent-secondary antibody. After samples were counterstained with DAPI, immunocytochemical images were obtained via confocal microscopy (LSM510, Carl Zeiss).
Quantification of oxidative stress. After stimulation with salusins, HUVECs were loaded with 2,7-dihydrodichlorofluorescein diacetate (Sigma-Aldrich) at 37°C for 30 min as previously described (14) . After cells were washed twice with PBS, the fluorescence intensity of the cells was measured with a fluorescent microplate reader (excitation: 488 nm and emission: 515 nm, Mithras LB940; Berthold Technologies).
Statistical analyses. Results are expressed as means Ϯ SE. Student's t-test was used to determine statistical differences between the two groups. Multiple comparisons were conducted with nonrepeatedmeasures one-way ANOVA followed by a post hoc Bonferroni's test. P values of Ͻ0.05 were considered statistically significant.
RESULTS

Neutralization of endogenous salusin-␤ suppresses monocyte adhesion to aortic walls in Ldlr
Ϫ/Ϫ mice. Our previous data showed that feeding HCD for 12 wk to Ldlr Ϫ/Ϫ mice markedly induced atherosclerotic lesions in the aortic arch (15) . In contrast, there were no detectable atherosclerotic lesions in HCD-fed Ldlr Ϫ/Ϫ mice compared with chow-fed Ldlr Ϫ/Ϫ mice at 2 wk after the initiation of the HCD (data not shown). Immunohistochemical experiments involving MOMA-2 disclosed adherent monocytes/macrophages on the luminal surface of the inferior surface of the aortic arch of HCD-fed Ldlr Ϫ/Ϫ mice treated with nonimmune rabbit serum for 2 wk (Fig. 1A) . Adhesion of monocytes/macrophages weakened af- ter the infusion of antiserum against salusin-␤. It is noteworthy that the administration of antiserum did not influence systolic blood pressure, leukocyte numbers (either composition) in peripheral blood (Table 2) , or plasma lipid profiles in the mice studied (Table 3) . Real-time RT-PCR analysis demonstrated elevated mRNA expression levels of CD68 as a monocyte/ macrophage marker, adhesion molecules (VCAM-1 and Eselectin), chemokine monocyte chemoattractant protein (MCP)-1, and cytokine IL-1␤, but not ICAM-1 and TNF-␣, in the aorta of HCD-fed Ldlr Ϫ/Ϫ mice (Fig. 1B) . Infusion of salusin-␤ antiserum significantly reduced expression levels of CD68, VCAM-1, MCP-1, and IL-1␤, but not E-selectin, in the aorta in HCD-fed mice. Immunohistochemical analysis indicated that VCAM-1 protein expression in aortic ECs in HCDfed Ldlr Ϫ/Ϫ mice treated with salusin-␤ antiserum was much weaker than that in the presence of nonimmune serum (Fig.  1C) . Furthermore, nuclear localization of p50 NF-B in aortic ECs was detected in HCD-fed Ldlr Ϫ/Ϫ mice infused with nonimmune serum but not with salusin-␤ antiserum (Fig. 1D) .
Salusin-␤ accelerates monocyte adhesion to cultured ECs through upregulation of VCAM-1.
To establish whether salusin-␤ directly promotes monocyte-EC adhesion, in vitro adhesion experiments were conducted. Pretreatment of HUVECs with salusin-␤, but not with salusin-␣, promoted the adhesion of THP-1 monocytes to HUVECs in concentrations above 10 nM (Fig. 2A) . Salusin-␣ did not display any inhibitory effects on the salusin-␤-induced adhesion of THP-1 monocytes to HUVECs (Fig. 2B ), although our previous study (29) demonstrated that salusin-␣ opposed the salusin-␤-facilitated formation of foam cells in human monocyte-derived macrophages. To assess the effects of salusin-␤ on THP-1 monocytes, we also stimulated THP-1 cells with salusin-␤ at 30 nM in a similar manner in HUVECs; however, the effects of this treatment on the THP-1/HUVEC adhesion was almost negligible (data not shown). The MTT assay revealed no cytotoxicity of either salusin-␣ or -␤ in HUVECs in the concentration range of 1-100 nM (Fig. 2C) .
Real-time RT-PCR analysis identified enhanced mRNA expression levels of ICAM-1, VCAM-1, MCP-1, and IL-1␤, but not E-selectin and TNF-␣, after treatment of HUVECs with salusin-␤ (Fig. 3A) ; in contrast, salusin-␣ at a relatively higher concentration (30 nM) failed to demonstrate a similar effect. Immunoblot analysis disclosed markedly elevated protein expression levels of VCAM-1 due to the action of salusin-␤ in parallel with the changes in mRNA levels (Fig. 3B) . Salusin-␤ induction of ICAM-1 mRNA was not reflected in its protein expression via an unknown mechanism. (25) and Bay 11-7082 (16), suppressed salusin-␤-induced mRNA expression of VCAM-1 (Fig. 4A) , which led to inhibition of salusin-␤-induced adhesion of THP-1 cells to HUVECs (Fig. 4B) . It is noteworthy that salusin-␤-induced VCAM-1 induction was attenuated substantially by treatment with the free radical scavenger NAC (Fig.  4A) (26) . In addition, LY-294002, an inhibitor for the phosphatidylinositol 3-kinase (PI3K)/Akt signal (13) , was effective in suppressing salusin-␤-induced VCAM-1 expression (Fig.  4C) . In contrast, treatment with U-0126, an inhibitor for the ERK signal (13), accelerated the salusin-␤-induced VCAM-1 induction in HUVECs (Fig. 4C) .
NF-B signal is required for salusin-␤-induced monocyte adhesion to ECs. Treatment of HUVECs with NF-B inhibitors, namely, curcumin
Immunocytochemical experiments involving p50 NF-B clearly demonstrated that treatment of HUVECs with salusin-␤, but not with salusin-␣, enhanced nuclear translocation of NF-B (Fig. 5A) ; moreover, NF-B translocation was blocked upon the introduction of NAC to the culture medium. It is well known that IB-␣, an endogenous inhibitor of NF-B, is degraded in a phosphorylation-dependent manner when the NF-B signal is activated (2) . As expected, IB-␣ was phosphorylated and degraded after treatment with salusin-␤ (Fig. 5B) .
NADPH oxidase family members and oxidative stress are upregulated in salusin-␤-stimulated ECs. Real-time RT-PCR analysis showed that salusin-␤ upregulated mRNA expression levels of NADPH oxidase family member Nox2 but not Nox4 and xanthine dehydrogenase/oxidase (Fig.   6A ); in contrast, salusin-␣ at a relatively higher concentration (30 nM) did not induce such expressions. The dihydrodichlorofluorescein assay revealed an acceleration of oxidative stress in HUVECs at a relatively lower concentration of salusin-␤ (3 nM; Fig. 6B) .
DISCUSSION
The present study demonstrated that endogenous salusin-␤ facilitates the adhesion of monocytes/macrophages to aortic ECs in HCD-fed Ldlr Ϫ/Ϫ mice ( Fig. 1) and that salusin-␤ directly upregulates the proinflammatory adhesion molecule VCAM-1 in ECs through redox-sensitive transcription factor NF-B (Figs. 4  and 5 ). To the best of our knowledge, this report is the first to document a role of salusin-␤ in vascular ECs.
Many earlier investigations have described the induction of adhesion molecules (e.g., ICAM-1, VCAM-1, and selectins) in ECs during the initiation and progression of atherosclerosis (9, 20, 34) . A growing body of evidence suggests that this process is mediated mainly through NF-B signals (2, 4, 10, 32) . Nuclear translocation of NF-B in aortic ECs in atherosclerotic mice has been noted as a hallmark of its activation (5, 33) . Interestingly, Gareus et al. (4) reported that EC-specific downregulation of NF-B signals involving the Cre/loxP system resulted in the amelioration of atherosclerotic lesions in ApoE Ϫ/Ϫ mice, indicating that NF-B signals in ECs largely contribute to the development of atherosclerotic lesions. These findings, in concert with the present data, indicate that monocyte adhesion to vascular ECs in the early phase of atherosclerosis is mediated, at least in part, through salusin-␤-stimulated NF-B signals, which may accelerate the progression of the disease.
The present data show that salusin-␤ selectively upregulated the expression of VCAM-1 but not ICAM-1 and E-selectin in cultured ECs, despite activation of their common transcription factor, NF-B (Fig. 3) . However, this is not surprising, since a previous investigation (19) similarly suggested that treatment of human corneal fibroblasts with polyinosinic-polycytidic acid upregulated the expression of VCAM-1 but not E-selectin through NF-B signals, in which the VCAM-1 induction was cancelled by the pharmacological inhibition of PI3K. This observation resembles our present data, indicating that selective VCAM-1 induction in salusin-␤-stimulated ECs is mediated through the PI3K/Akt signal as well as through the NF-B signal (Fig.  4C) . The present data further show that the salusin-␤-induced VCAM-1 induction was promoted by pharmacological inhibition of the ERK signal (Fig. 4C) . This is consistent with a previous report (11) indicating that ERK inhibition significantly upregulated VEGF-induced adhesion molecules in HUVECs. Thus, the mechanisms underlying the salusin-␤-induced upregulation of VCAM-1 are likely to be highly complicated. Although the reasons why VCAM-1 is selectively upregulated by salusin-␤ are still unclear, we speculate that the complexed modulation of NF-B signal by PI3K/Akt, ERK, and/or other unknown factors may result in such biased induction of VCAM-1 among adhesion molecules.
NADPH oxidase (8) and xanthine oxidase (7) reportedly have a dominant role in the production of ROS during the development of atherosclerosis. It has been documented that Nox2 is highly expressed in vascular ECs and macrophages in atherosclerotic lesions in ApoE Ϫ/Ϫ mice, thereby promoting the generation of superoxide and decreasing the bioavailability of nitric oxide; thus, systemic deficiency of Nox2 led to inhibition of athrosclerotic lesions in ApoE Ϫ/Ϫ mice (6). Furthermore, EC-specific overexpression of Nox2 in transgenic mice resulted in the induction of adhesion molecules in aortic ECs (3) . Similarly, Nox4 is known to be enriched in vascular ECs; however, Nox4 exerts vasoprotective roles in mice treated with femoral artery ligation for ischemia-reperfusion injury or ANG II-infused mice through its ability to generate H 2 O 2 (23) . The present data show that salusin-␤ selectively promoted the induction of Nox2 and oxidative stress in ECs (Fig. 6) . Thus, salusin-␤-induced NF-B activation may be mediated at least in part through oxidative stress derived from Nox2-generated superoxide.
Previously, we (17) showed that the chronic infusion of salusin-␤ promotes the infiltration of monocytes/macrophages in the aortic wall and macrophage foam cell formation, leading to the development of atherosclerosis in ApoE Ϫ/Ϫ mice. Moreover, the development of atherosclerotic lesions in ApoE Ϫ/Ϫ mice is inhibited by an infusion of anti-salusin-␤ antiserum, which suggests that both exogenous and endogenous salusin-␤ can exacerbate the disease state. It is noteworthy that the antiserum and its infusion procedure used in this investigation were identical to those used in previous studies (17, 22) . Thus, anti-salusin-␤ antiserum is likely to exert anti-inflammatory effects directly on vascular ECs at its effective dose for ApoE Ϫ/Ϫ mice (17).
An earlier study (24) suggested that proliferation and intracellular Ca 2ϩ mobilization in VSMCs and fibroblasts are induced by salusin-␤, which peaked at concentrations above 10 nM; moreover, salusin-␣ displayed similar, albeit weaker, effects on cells compared with salusin-␤. Furthermore, the present data indicate that salusin-␤ induced the expression of VCAM-1 in ECs and accelerated monocyte-EC adhesion, reaching its plateau effects at concentrations above 10 nM (Fig. 2A) . Salusin-␣ failed to prevent salusin-␤-induced monocyte-EC adhesion (Fig. 2B) . On the other hand, acetylated LDL-induced formation of foam cells in human monocyte-derived macrophages was accelerated markedly upon treatment with salusin-␤, which attained its maximal effects at 0.6 nM; in contrast, salusin-␣ significantly attenuated the foam cell formation (29), indicating Our previous study (27) proposed that salusin-␤ was enriched in coronary atherosclerotic lesions in patients with acute coronary syndrome, which is prominent in VSMCs, fibloblasts, and macrophage foam cells in lesions. Therefore, it is not surprising that salusin-␤ upregulation in vascular component cells and/or immune cells elicits inflammatory responses in adjacent ECs. Currently, a procedure for the measurement of serum concentrations of salusin-␤ is under development (22) ; as a result, the implications of serum salusin-␤ in atherosclerosis remain obscure. In contrast, salusin-␣ serum concentrations correlate negatively with severity of carotid atherosclerosis in essential hypertensive patients (31); thus, salusin-␣ may be a suitable biomarker for atherosclerotic diseases as well as an antiatherosclerotic agent.
In conclusion, our findings demonstrated, for the first time, that salusin-␤ exerts a proinflammatory effect on vascular ECs and that salusin-␤ facilitates NF-B signals. In a manner consistent with our previous report indicating that salusin-␤ facilitates macrophage foam cell formation and VSMC proliferation, the present investigation disclosed that salusin-␤ plays multiple roles in atherogenesis. Thus, antisalusin-␤ therapy involving the development of salusin-␤ receptor antagonists may afford a novel strategy for controlling atherosclerosis. Future studies are necessary to identify the specific receptors for salusins and its roles in other inflammatory vascular diseases, including aortitis and diabetic angiopathy. 
